William K. Oh, MD

Chief Scientific Officer and Chairman of the Science Advisory Board

Dr. William Oh is the Chief of the Division of Hematology and Medical Oncology at Mount Sinai Hospital in New York City; Professor of Medicine and Urology and Ezra M. Greenspan Professor in Clinical Cancer Therapeutics at the Icahn School of Medicine at Mount Sinai; and Associate Director for Clinical Research at The Tisch Cancer Institute at Mount Sinai.

Dr. Oh is an internationally recognized expert in the management of genitourinary (GU) malignancies (including prostate, renal, bladder and testicular cancers) and in using biological data banks to advance the understanding of cancer and cancer treatment. Dr. Oh’s research interests include the role of chemotherapy and novel therapeutics in advanced prostate cancer. A leading investigator in the use of neoadjuvant chemotherapy in men with high-risk localized prostate cancer, he has served as the principal investigator of multiple clinical trials in prostate and other GU cancers.

Before joining Mount Sinai, Dr. Oh was an attending physician at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital, both in Boston, Massachusetts. Dr. Oh became a national leader in developing clinical trials examining neoadjuvant chemotherapy in men with high-risk localized prostate cancer as well as in studying the role of platinum chemotherapy in castration-resistant prostate cancer. At Dana-Farber, Dr. Oh served as Clinical Director of the Lank Center for Genitourinary Oncology and Director of the Gelb Center for Translational Research and was the founding Chair of the Data and Safety Monitoring Committee for Phase I/II Trials at the Dana-Farber/Harvard Cancer Center. There, he developed a large clinical database and specimen repository for GU cancers that enrolled more than 8,000 patients with prostate, renal and bladder cancer.

Dr. Oh has been inducted into the American Society for Clinical Investigation and has been repeatedly selected as a Top Doctor in New York Magazine, Castle Connolly, Best Doctors and Super Doctors.

Dr. Oh has published more than 250 original articles, reviews and book chapters (click here) on topics relating to prostate, renal, bladder and testicular cancers. He has edited three books on prostate cancer. In addition to reviewing for prominent journals such as the New England Journal of Medicine, Journal of Clinical Oncology, and Cancer. Dr. Oh co-edits “Testicular Cancer” for Up to Date and is Associate Editor of CA: A Cancer Journal for Clinicians. He also serves on the editorial boards of Clinical Genitourinary Cancer and American Journal of Hematology and Oncology.

Dr. Oh received a B.S. from Yale University and obtained his medical degree from New York University School of Medicine. He completed his residency in internal medicine at Brigham and Women’s Hospital and a fellowship in medical oncology at the Dana-Farber Cancer Institute.

Media Links

Dr. Oh discusses risk factors for prostate cancer.

Dr. Oh discusses reducing prostate cancer risk.

Dr. Oh discusses PSA tests and false positives.

Dr. Oh discusses the symptoms of prostate cancer.

Dr. Oh discusses prostate cancer monitoring.

Dr. Oh discusses treatment options for prostate cancer.

Dr. Oh discusses what to ask about prostate cancer.

Dr. Oh discusses advanced prostate cancer and making the most of doctor appointments.

Dr. Oh discusses combination studies in prostate cancer.

Dr. Oh discusses the place of novel agents focused on the androgen axis at the 2013 ASCO meeting.

Dr. Oh discusses various issues in metastatic castration resistant prostate cancer.